Article
Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi.
Malaria journal - 29 Nov 2016
Ravenhall Matt, Benavente Ernest Diez, Mipando Mwapatsa, Jensen Anja T R, Sutherland Colin J, Roper Cally, Sepúlveda Nuno, Kwiatkowski Dominic P, Montgomery Jacqui, Phiri Kamija S, Terlouw Anja, Craig Alister, Campino Susana, Ocholla Harold, Clark Taane G
Abstract excerpt
BACKGROUND: Malawi experienced prolonged use of sulfadoxine/pyrimethamine (SP) as the front-line anti-malarial drug, with early replacement of chloroquine and delayed introduction of artemisinin-based combination therapy. Extended use of SP, and its continued application in pregnancy is impacting the genomic variation of the Plasmodium falciparum population. METHODS: Whole genome sequence data of P. falciparum...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
